SCHEMBL21669712

SCHEMBL21669712

COc1ncccc1C(=O)CN

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
P2RX7 Q99572 1/20 0.46
MAPT P10636 2/20 0.46
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 3/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PPARG P37231 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
SLC13A5 Q86YT5 1/20 0.41
RAB9A P51151 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CTSD P07339 1/20 0.40
KMT2A Q03164 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221020 0.85 MAPT (0.48) ALDH1A1P2RX7MAPTGAATDP1
SCHEMBL13545148 0.85 MAPT (0.47) ALDH1A1P2RX7MAPTGAATDP1
SCHEMBL30623889 0.83 ALDH1A1 (0.66) ALDH1A1P2RX7MAPTGAATDP1
SCHEMBL21669713 0.83 GAA (0.46) ALDH1A1P2RX7MAPTGAATDP1
SCHEMBL20837329 0.83 ALDH1A1 (0.66) ALDH1A1P2RX7MAPTGAATDP1
SCHEMBL1723847 0.81 RAB9A (0.58) ALDH1A1MAPTGAATDP1HPGD
SCHEMBL29980732 0.81 RAB9A (0.58) ALDH1A1MAPTGAATDP1HPGD
SCHEMBL6609846 0.81 TDP1 (0.47) ALDH1A1P2RX7MAPTGAATDP1
SCHEMBL949562 0.80 TDP1 (0.50) ALDH1A1MAPTGAATDP1LMNA
SCHEMBL21645630 0.80 GAA (0.52) ALDH1A1P2RX7MAPTGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3829559-B1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION MERCK SHARP & DOHME LLC (US) 2026-05-13 EP disclosed
US-12331044-B2 Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection MERCK SHARP & DOHME LLC (US) 2025-06-17 US disclosed
US-20210276992-A1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION MERCK SHARP & DOHME CORP. (US) 2021-09-09 US disclosed
US-20210276992-A1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION MERCK SHARP & DOHME CORP. (US) 2021-09-09 US disclosed
WO-2020028150-A1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION MERCK SHARP & DOHME CORP. (US) 2020-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12331044-B2 Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection HDAC1, HDAC11, HDAC10 ALDH1A1 160/4885P2RX7 4127/4885MAPT 3101/4885
US-20210276992-A1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION HDAC1, HDAC11, HDAC10 ALDH1A1 160/4885P2RX7 4127/4885MAPT 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.